Brief: Infinity Pharma Reports Q3 Loss Per Share Of $0.16
09/11/2020 22:23
Nov 9 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* Q3 LOSS PER SHARE $0.16
* Q3 EARNINGS PER SHARE ESTIMATE $-0.16 -- REFINITIV IBES
DATA
* CASH RUNWAY THROUGH 2021
* EXPECTS NET LOSS FOR 2020 TO RANGE FROM $35 MILLION TO $45
MILLION
* INFINITY PHARMACEUTICALS - EXPECTS TO END 2020 WITH
YEAR-END
CASH, CASH EQUIVALENTS, AVAILABLE-FOR-SALE SECURITIES BALANCE
$25 MILLION - $35 MILLION
Source text for Eikon: ID:nBwc6g18ma
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX